β-Catenin and the morphogenesis of colorectal cancer

Virchows Archiv

Volumn 441, Issue 1, 2002, Pages 1-11

  Brabletz, Thomas ^a   Jung, Andreas ^a   Kirchner, Thomas ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Catenin; APC; Colorectal cancer; Microenvironment; Morphogenesis

Indexed keywords

BETA CATENIN;

ADENOCARCINOMA; COLON POLYPOSIS; COLORECTAL CANCER; DISEASE COURSE; EMBRYO DEVELOPMENT; GENE MUTATION; HUMAN; MORPHOGENESIS; PRIORITY JOURNAL; REVIEW; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

BETA CATENIN; COLORECTAL NEOPLASMS; CYTOSKELETAL PROTEINS; HUMANS; MUTATION; TRANS-ACTIVATORS;

EID: 0036301919     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-002-0642-9     Document Type: Review

References (103)

1. Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers
2. Tumor environment: A potent driving force in colorectal cancer?
3. Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium
4. The chromatin remodelling factor Brg-1 interacts with beta-catenin to promote target gene activation
5. Cadherins, catenins and APC protein: Interplay between cytoskeletal complexes and signaling pathways
6. Cadherins and catenins: Role in signal transduction and tumor progression
7. Functional interaction of beta-catenin with the transcription factor LEF-1
8. Linking colorectal cancer to Wnt signaling
9. Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front
10. β-Catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer
11. Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas
12. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment
13. Wnt signaling: A common theme in animal development
14. Drosophila Tcf and Groucho interact to repress Wingless signalling activity
15. TCF/LEF factor earn their wings
16. The metalloproteinase Matrilysin is a target of β-catenin transactivation in intestinal tumors
17. Beta-catenin expression pattern in primary oesophageal squamous cell carcinoma. Relationship with clinicopathologic features and clinical outcome
18. The adenomatous polyposis coli protein: In the limelight out at the edge
19. Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability
20. Epithelial mesenchymal transition by c-Fos estrogen receptor activation involves nuclear translocation of beta-catenin and upregulation of beta-catenin/lymphoid enhancer binding factor-1 transcriptional activity
21. Mutations in the APC tumour suppressor gene cause chromosomal instability
22. Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon
23. Up-regulation of the ectodermal-neural cortex 1 (ENC1) gene, a downstream target of the beta-catenin/T-cell factor complex, in colorectal carcinomas
24. Tumor de-differentiation: An important step in tumor invasion
25. Structure and expression of the human gene for the matrix metalloproteinase matrilysin
26. Invasion of human colorectal carcinoma cells is promoted by endogenous basic fibroblast growth factor
27. Matrix gene expression analysis and cellular phenotyping in chordoma reveals focal differentiation pattern of neoplastic cells mimicking nucleus pulposus development
28. The Wnt/Wg signal transducer beta-catenin controls fibronectin expression
29. Identification and characterization of the familial adenomatous polyposis coli gene
30. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene
31. Insulin-like growth factor II supply modifies growth of intestinal adenoma in Apc(Min/+) mice
32. Identification of c-MYC as a target of the APC pathway
33. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs
34. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers
35. Expression of the invasion factor laminin γ2 in colorectal carcinomas is regulated by β-catenin
36. Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer
37. APC mutations in colorectal tumors with mismatch repair deficiency
38. Involvement of Tcf/Lef in establishing cell types along the animal-vegetal axis of sea urchins
39. Beta-catenin controls hair follicle morphogenesis and stem cell differentiation in the skin
40. Cadherin-catenin expression in primary colorectal cancer: A survival analysis
41. Alteration of beta-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients
42. The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D(1), and p16(INK4A) and is a region of low proliferation
43. A role for the adenomatous polyposis coli protein in chromosome segregation
44. Asef, a link between the tumor suppressor APC and G-protein signaling
45. Intestinal epithelial-mesenchymal cell interactions
46. Lessons from hereditary colorectal cancer
47. Identification of FAP locus genes from chromosome 5q21
48. Patterning and nuclear beta-catenin expression in the colonic adenoma-carcinoma sequence: Analogies with embryonic gastrulation
49. Metaplasia, intraepithelial neoplasia and early cancer of the stomach are related to dedifferentiated epithelial cells defined by cytokeratin-7 expression in gastritis
50. Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis
51. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma
52. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4
53. Mouse models for human familial adenomatous polyposis
54. Wnt/(beta)-catenin signaling regulates the expression of the homeobox gene Cdx1 in embryonic intestine
55. The microenvironment of the tumour-host interface
56. Tumor invasion and metastasis: An imbalance of positive and negative regulation
57. Phosphorylation of beta-catenin and epidermal growth factor receptor by intestinal trefoil factor
58. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling
59. Nuclear beta-catenin is required to specify vegetal cell fates in the sea urchin embryo
60. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas
61. Down-regulation of beta-catenin TCF signaling is linked to colonic epithelial cell differentiation
62. Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer
63. Nuclear accumulation of beta-catenin in intestinal-type gastric carcinoma: Correlation with early tumor invasion
64. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos
65. IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition
66. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC
67. Restoration of epithelial cell polarity in a colorectal cancer cell line by suppression of beta-catenin/T-cell factor 4-mediated gene transactivation
68. Deposition of laminin 5 in epidermal wounds regulates integrin signaling and adhesion
69. Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer
70. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1
71. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways
72. Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis
73. Human colorectal cancers with an intact p16/cyclin D1/pRb pathway have up-regulated p16 expression and decreased proliferation in small invasive tumor clusters
74. A causal role for E-cadherin in the transition from adenoma to carcinoma
75. Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation
76. Tumors are unique organs defined by abnormal signaling and context
77. LEF-1, a nuclear factor coordinating signaling inputs from wingless and decapentaplegic
78. Id2 is a target of the beta-catenin/TCF pathway in colon carcinoma
79. Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells
80. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis
81. The APC tumour suppressor has a nuclear export function
82. Association of the APC gene product with beta-catenin
83. A phosphatase associated with metastasis of colorectal cancer
84. Loss of immunohistochemical E-cadherin expression in colon cancer is not due to structural gene alterations
85. Tyrosine phosphorylation of beta-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells
86. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression
87. Top-down morphogenesis of colorectal tumors
88. Frequent activation of the beta-catenin-Tcf signaling pathway in nonfamilial colorectal carcinomas with microsatellite instability
89. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway
90. The adenomatous polyposis coli (APC) tumour suppressor-genetics, function and disease
91. Somatic Apc mutations are selected upon their capacity to inactivate the beta-catenin downregulating activity
92. Differential expression of laminin-5 subunits and integrin receptors in human colorectal neoplasia
93. Association of the APC tumor suppressor protein with catenins
94. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells
95. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells
96. Pluripotent cells (stem cells) and their determination and differentiation in early vertebrate embryogenesis
97. APC in the regulation of intestinal crypt fission
98. CRM1- and Ran-independent nuclear export of beta-catenin
99. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway
100. General mechanisms of metastasis
101. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis
102. Evidence that APC regulates survivin expression: A possible mechanism contributing to the stem cell origin of colon cancer
103. Regulation of vascular endothelial growth factor by the WNT and K-ras pathways in colonic neoplasia